Compare Eli Lilly And Co (LLY) vs Warner Music Group Corp (WMG) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Eli Lilly And Co vs Warner Music Group Corp — how do they compare? Eli Lilly And Co trades at $1,161 (market cap $1.02T), while Warner Music Group Corp trades at $28.06 (market cap $14.64B). The key difference: Eli Lilly And Co is far larger — about 69.7× Warner Music Group Corp's market cap, and Warner Music Group Corp pays the higher dividend (2.71%). Which is the better fit depends on your goals.
| LLY | WMG | |
|---|---|---|
Market Cap | $1.02T | $14.64B |
Sector | Health | Media |
52-Week High | $1.24K | $34.72 |
52-Week Low | $625.65 | $23.65 |
Enterprise Value | $1.06T | $18.84B |
Dividend Yield | 0.6% | 2.71% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Eli Lilly (LLY) trades at $1,150.86, down 2.39% on the day, with a bullish technical signal from moving averages and strong fundamental performance. The company reported robust earnings beats in recent quarters, with Q1 2026 EPS of $8.55 exceeding expectations by 23%. Revenue surged to $65.18 billion in 2025, driving a net income margin of 34.99%. Recent news highlights LLY's $2.8 billion acquisition of AtaiBeckley to expand its neuroscience pipeline, signaling strategic growth in mental health treatments.
Outlook remains positive with analyst consensus price target of $1,380 implying 20% upside, supported by 73% buy ratings. Key risks include high valuation multiples (P/E 41.89) and rising debt levels, though operating cash flow growth to $16.81 billion in 2025 provides financial flexibility. Investors should monitor Q2 2026 earnings on August 5 for continued execution on weight-loss drug demand and integration of recent acquisitions.
Warner Music Group (WMG) trades at $28.08, down 0.88% on the day, with a bearish technical signal and mixed earnings history. Revenue growth is steady, reaching $6.71B in 2025, but net income margin has declined to 5.44%. Recent developments include a strategic renewal with NetEase Cloud Music and the acquisition of AI startup Sureel AI, enhancing IP monetization capabilities in the evolving music industry.
The stock offers a 44% upside to the consensus price target of $40.40, supported by strong analyst buy ratings (66.66%), but faces risks from competitive pressures and margin compression. Investors should weigh the high P/E ratio of 33.73 against growth initiatives and cash flow improvements projected for 2026.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Eli Lilly And Co
Eli Lilly is a drug firm with a focus on neuroscience, endocrinology, cancer, and immunology. Lilly's key products include Verzenio for cancer
Read more on LLY →About Warner Music Group Corp
Warner Music Group is the third largest of the three major global record labels, with Vivendi's Universal Music in first and Sony Music in second. Warner's larger segment, recorded music, consists of iconic labels like Atlantic Records, Warner Records, and Parlophone Records and popular artists such as Ed Sheeran, Cardi B, Dua Lipa, and Blake Shelton. Warner Chappell, the firm's publishing arm, is the home to over 65,000 composers and songwriters with over a million copyrights represented. Warner is controlled by Access Industries, which owns an 84% economic interest and 99% of voting rights.
Read more on WMG →
